Mingo 團隊的 GLP-1 指南。https://mingo.fit/zh-hant/%E9%83%A8%E8%90%BD%E6%A0%BC/zh-Hanthttps://mingo.fit/zh-hant/blog/ozempic-%E9%96%8B%E5%A7%8B%E6%99%82%E9%96%93%E8%A1%A8%EF%BC%9A%E4%BD%95%E6%99%82%E9%A0%90%E6%9C%9F%E9%AB%94%E9%87%8D%E6%B8%9B%E8%BC%95%E5%8F%8A%E7%B5%90%E6%9E%9C/https://mingo.fit/zh-hant/blog/ozempic-%E9%96%8B%E5%A7%8B%E6%99%82%E9%96%93%E8%A1%A8%EF%BC%9A%E4%BD%95%E6%99%82%E9%A0%90%E6%9C%9F%E9%AB%94%E9%87%8D%E6%B8%9B%E8%BC%95%E5%8F%8A%E7%B5%90%E6%9E%9C/Ozempic 需要多久才會見效：0.25 mg 的第一個月、食慾與血糖何時改變、體重為何逐漸變化，以及應該記錄什麼。Sat, 21 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/glp-1-%E4%BD%BF%E7%94%A8%E8%80%85%E7%9A%84%E5%8D%A1%E8%B7%AF%E9%87%8C%E8%A8%88%E7%AE%97%E6%87%89%E7%94%A8%E7%A8%8B%E5%BC%8F%EF%BC%9A%E6%9C%80%E9%87%8D%E8%A6%81%E7%9A%84%E6%98%AF%E4%BB%80%E9%BA%BC/https://mingo.fit/zh-hant/blog/glp-1-%E4%BD%BF%E7%94%A8%E8%80%85%E7%9A%84%E5%8D%A1%E8%B7%AF%E9%87%8C%E8%A8%88%E7%AE%97%E6%87%89%E7%94%A8%E7%A8%8B%E5%BC%8F%EF%BC%9A%E6%9C%80%E9%87%8D%E8%A6%81%E7%9A%84%E6%98%AF%E4%BB%80%E9%BA%BC/在使用 GLP-1 藥物時，選擇卡路里計算應用程式需注意快速記錄、蛋白質和水分，還有劑量和副作用的記錄。Fri, 20 Mar 2026 00:00:00 GMT營養https://mingo.fit/zh-hant/blog/%E9%A3%9F%E7%89%A9%E8%BF%BD%E8%B9%A4%E6%87%89%E7%94%A8%E7%A8%8B%E5%BC%8F%EF%BC%9A%E7%9B%A3%E6%8E%A7%E7%87%9F%E9%A4%8A%E7%B4%A0%E8%88%87glp-1%E6%94%AF%E6%8F%B4/https://mingo.fit/zh-hant/blog/%E9%A3%9F%E7%89%A9%E8%BF%BD%E8%B9%A4%E6%87%89%E7%94%A8%E7%A8%8B%E5%BC%8F%EF%BC%9A%E7%9B%A3%E6%8E%A7%E7%87%9F%E9%A4%8A%E7%B4%A0%E8%88%87glp-1%E6%94%AF%E6%8F%B4/食物追蹤應用程式應為使用GLP-1藥物的人記錄蛋白質、纖維和液體，並將劑量和副作用與餐點一起記錄。Thu, 19 Mar 2026 00:00:00 GMT營養https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%E8%97%A5%E7%89%A9%E5%92%8C%E8%BF%BD%E8%B9%A4%E6%8C%87%E5%8D%97/https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%E8%97%A5%E7%89%A9%E5%92%8C%E8%BF%BD%E8%B9%A4%E6%8C%87%E5%8D%97/簡單介紹獲批用於體重管理的 GLP-1 藥物、劑量步驟運作方式，以及服用期間應追蹤的事項。Wed, 18 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/zepbound%EF%BC%9A%E9%80%99%E7%A8%AE%E6%B3%A8%E5%B0%84%E5%8A%91%E5%A6%82%E4%BD%95%E5%AE%89%E5%85%A8%E5%9C%B0%E5%B9%AB%E5%8A%A9%E6%B8%9B%E9%87%8D/https://mingo.fit/zh-hant/blog/zepbound%EF%BC%9A%E9%80%99%E7%A8%AE%E6%B3%A8%E5%B0%84%E5%8A%91%E5%A6%82%E4%BD%95%E5%AE%89%E5%85%A8%E5%9C%B0%E5%B9%AB%E5%8A%A9%E6%B8%9B%E9%87%8D/Zepbound（tirzepatide）的用途、適用物件、劑量及主要安全警告，根據FDA的處方資訊。Tue, 17 Mar 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/semaglutide-%E7%94%A8%E6%96%BC%E6%B8%9B%E9%87%8D%E5%92%8C-glp-1-%E4%BD%BF%E7%94%A8%E8%80%85%EF%BC%9A%E9%9C%80%E8%A6%81%E4%BA%86%E8%A7%A3%E7%9A%84%E5%85%A7%E5%AE%B9/https://mingo.fit/zh-hant/blog/semaglutide-%E7%94%A8%E6%96%BC%E6%B8%9B%E9%87%8D%E5%92%8C-glp-1-%E4%BD%BF%E7%94%A8%E8%80%85%EF%BC%9A%E9%9C%80%E8%A6%81%E4%BA%86%E8%A7%A3%E7%9A%84%E5%85%A7%E5%AE%B9/Semaglutide 是 Ozempic、Wegovy 和 Rybelsus 的成分。檢視哪個品牌獲得了哪些批准、標籤劑量、試驗結果和副作用。Mon, 16 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/zepbound-%E5%8A%91%E9%87%8F%E8%A8%88%E7%95%AB%EF%BC%9A%E6%AF%8F%E9%80%B1%E8%A8%88%E7%95%AB%E3%80%81%E8%AA%BF%E6%95%B4%E5%92%8C%E6%8F%90%E7%A4%BA/https://mingo.fit/zh-hant/blog/zepbound-%E5%8A%91%E9%87%8F%E8%A8%88%E7%95%AB%EF%BC%9A%E6%AF%8F%E9%80%B1%E8%A8%88%E7%95%AB%E3%80%81%E8%AA%BF%E6%95%B4%E5%92%8C%E6%8F%90%E7%A4%BA/根據 FDA 標籤的 Zepbound 劑量計畫：2.5 mg 起始，每 4 週增加 2.5 mg，維持劑量為 5-15 mg，以及錯過劑量時的處理方法。Sun, 15 Mar 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%EF%BC%9A%E5%A6%82%E4%BD%95%E8%BF%BD%E8%B9%A4%E3%80%81%E7%AE%A1%E7%90%86%E5%92%8C%E6%9C%80%E5%A4%A7%E5%8C%96%E7%B5%90%E6%9E%9C/https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%EF%BC%9A%E5%A6%82%E4%BD%95%E8%BF%BD%E8%B9%A4%E3%80%81%E7%AE%A1%E7%90%86%E5%92%8C%E6%9C%80%E5%A4%A7%E5%8C%96%E7%B5%90%E6%9E%9C/如何充分利用 GLP-1 藥物：按處方服用，記錄劑量、蛋白質、液體和症狀，並保持飲食和活動。Sat, 14 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%E6%B3%A8%E5%B0%84%E5%8A%91%E7%9A%84%E5%AF%A6%E7%94%A8%E6%8C%87%E5%8D%97/https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%E6%B3%A8%E5%B0%84%E5%8A%91%E7%9A%84%E5%AF%A6%E7%94%A8%E6%8C%87%E5%8D%97/GLP-1 減重注射劑的作用機制、獲批用於體重管理的藥物、劑量安排、副作用及追蹤要點。Fri, 13 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/rybelsus%EF%BC%9A%E5%85%B6%E9%81%8B%E4%BD%9C%E5%8E%9F%E7%90%86%E3%80%81%E5%89%AF%E4%BD%9C%E7%94%A8%E5%8F%8A%E6%AF%8F%E6%97%A5%E8%BF%BD%E8%B9%A4%E6%8A%80%E5%B7%A7/https://mingo.fit/zh-hant/blog/rybelsus%EF%BC%9A%E5%85%B6%E9%81%8B%E4%BD%9C%E5%8E%9F%E7%90%86%E3%80%81%E5%89%AF%E4%BD%9C%E7%94%A8%E5%8F%8A%E6%AF%8F%E6%97%A5%E8%BF%BD%E8%B9%A4%E6%8A%80%E5%B7%A7/Rybelsus 是一種每日服用的 semaglutide 片劑，用於 2 型糖尿病。瞭解其作用機制、標籤劑量步驟、常見副作用及追蹤要點。Thu, 12 Mar 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/trulicity%EF%BC%9A%E9%80%99%E6%AC%BEglp-1%E8%97%A5%E7%89%A9%E5%A6%82%E4%BD%95%E5%B9%AB%E5%8A%A9%E8%BF%BD%E8%B9%A4%E9%AB%94%E9%87%8D%E6%B8%9B%E8%BC%95%E5%92%8C%E5%81%A5%E5%BA%B7%E7%8B%80%E6%B3%81/https://mingo.fit/zh-hant/blog/trulicity%EF%BC%9A%E9%80%99%E6%AC%BEglp-1%E8%97%A5%E7%89%A9%E5%A6%82%E4%BD%95%E5%B9%AB%E5%8A%A9%E8%BF%BD%E8%B9%A4%E9%AB%94%E9%87%8D%E6%B8%9B%E8%BC%95%E5%92%8C%E5%81%A5%E5%BA%B7%E7%8B%80%E6%B3%81/Trulicity（dulaglutide）是一種每週注射一次的2型糖尿病藥物，不是減肥藥。瞭解標籤上的劑量、副作用和追蹤內容。Wed, 11 Mar 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/glp-1-%E5%89%AF%E4%BD%9C%E7%94%A8%EF%BC%9A%E9%A0%90%E6%9C%9F%E8%88%87%E7%AE%A1%E7%90%86%E6%96%B9%E6%B3%95/https://mingo.fit/zh-hant/blog/glp-1-%E5%89%AF%E4%BD%9C%E7%94%A8%EF%BC%9A%E9%A0%90%E6%9C%9F%E8%88%87%E7%AE%A1%E7%90%86%E6%96%B9%E6%B3%95/最常見的 GLP-1 副作用是消化系統相關。檢視標籤率、緩解噁心的方法及需要醫師注意的警告訊號。Tue, 10 Mar 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%EF%BC%9A%E8%97%A5%E7%89%A9%E5%A6%82%E4%BD%95%E6%94%AF%E6%8C%81%E9%80%B2%E5%B1%95/https://mingo.fit/zh-hant/blog/glp-1-%E6%B8%9B%E9%87%8D%EF%BC%9A%E8%97%A5%E7%89%A9%E5%A6%82%E4%BD%95%E6%94%AF%E6%8C%81%E9%80%B2%E5%B1%95/GLP-1 藥物如何支援減重，哪些獲得批准，試驗結果顯示什麼，以及使用時需要追蹤什麼。Mon, 09 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/ozempic-%E6%B8%9B%E9%87%8D%EF%BC%9Aglp-1-%E4%BD%BF%E7%94%A8%E8%80%85%E7%9A%84%E5%AF%A6%E7%94%A8%E6%8C%87%E5%8D%97/https://mingo.fit/zh-hant/blog/ozempic-%E6%B8%9B%E9%87%8D%EF%BC%9Aglp-1-%E4%BD%BF%E7%94%A8%E8%80%85%E7%9A%84%E5%AF%A6%E7%94%A8%E6%8C%87%E5%8D%97/Ozempic 獲準用於 2 型糖尿病，而非減重。瞭解其作用、劑量步驟、Wegovy 試驗結果、副作用及追蹤要點。Sun, 08 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/%E6%B8%9B%E9%87%8D%E8%97%A5%E4%B8%B8%E5%92%8Cglp-1%E6%B3%A8%E5%B0%84%EF%BC%9A%E9%9C%80%E8%A6%81%E4%BA%86%E8%A7%A3%E7%9A%84%E5%85%A7%E5%AE%B9/https://mingo.fit/zh-hant/blog/%E6%B8%9B%E9%87%8D%E8%97%A5%E4%B8%B8%E5%92%8Cglp-1%E6%B3%A8%E5%B0%84%EF%BC%9A%E9%9C%80%E8%A6%81%E4%BA%86%E8%A7%A3%E7%9A%84%E5%85%A7%E5%AE%B9/處方減重藥丸與GLP-1注射的比較：各自的核準用途、劑量及標籤上的風險說明。Sat, 07 Mar 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/retatrutide%EF%BC%9A%E9%97%9C%E6%96%BCglp-1%E6%B8%9B%E9%87%8D%E7%9A%84%E5%BF%85%E8%A6%81%E8%B3%87%E8%A8%8A/https://mingo.fit/zh-hant/blog/retatrutide%EF%BC%9A%E9%97%9C%E6%96%BCglp-1%E6%B8%9B%E9%87%8D%E7%9A%84%E5%BF%85%E8%A6%81%E8%B3%87%E8%A8%8A/Retatrutide 是一種正在研究中的三重激動劑注射藥物，尚未獲得任何批准。瞭解第 2 期和第 3 期試驗報告，以及未知的部分。Fri, 06 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/saxenda-%E8%A7%A3%E9%87%8B%EF%BC%9A%E9%AB%94%E9%87%8D%E7%AE%A1%E7%90%86%E7%9A%84%E7%B6%9C%E5%90%88%E6%8C%87%E5%8D%97/https://mingo.fit/zh-hant/blog/saxenda-%E8%A7%A3%E9%87%8B%EF%BC%9A%E9%AB%94%E9%87%8D%E7%AE%A1%E7%90%86%E7%9A%84%E7%B6%9C%E5%90%88%E6%8C%87%E5%8D%97/Saxenda（liraglutide 3 mg）是一種每日注射的體重管理藥物。瞭解適用物件、劑量步驟、副作用及其差異。Thu, 05 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/tirzepatide%EF%BC%9A%E9%80%99%E7%A8%AE%E6%AF%8F%E9%80%B1%E6%B3%A8%E5%B0%84%E5%A6%82%E4%BD%95%E6%94%AF%E6%8C%81%E6%B8%9B%E9%87%8D/https://mingo.fit/zh-hant/blog/tirzepatide%EF%BC%9A%E9%80%99%E7%A8%AE%E6%AF%8F%E9%80%B1%E6%B3%A8%E5%B0%84%E5%A6%82%E4%BD%95%E6%94%AF%E6%8C%81%E6%B8%9B%E9%87%8D/Tirzepatide 活化 GIP 和 GLP-1 受體。檢視 Zepbound 和 Mounjaro 的核準用途、標籤劑量、試驗結果和副作用。Wed, 04 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/zepbound-%E8%88%87-wegovy%EF%BC%9A%E6%B8%9B%E9%87%8D%E7%9A%84%E9%97%9C%E9%8D%B5%E5%B7%AE%E7%95%B0/https://mingo.fit/zh-hant/blog/zepbound-%E8%88%87-wegovy%EF%BC%9A%E6%B8%9B%E9%87%8D%E7%9A%84%E9%97%9C%E9%8D%B5%E5%B7%AE%E7%95%B0/Zepbound (tirzepatide) vs Wegovy (semaglutide)：核准用途、劑量、頭對頭試驗結果和副作用，來自FDA標籤。Tue, 03 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/wegovy-%E8%97%A5%E4%B8%B8%EF%BC%9A%E4%BD%BF%E7%94%A8%E6%96%B9%E6%B3%95%E3%80%81%E7%9B%8A%E8%99%95%E3%80%81%E5%89%AF%E4%BD%9C%E7%94%A8%E5%92%8C%E7%B5%90%E6%9E%9C/https://mingo.fit/zh-hant/blog/wegovy-%E8%97%A5%E4%B8%B8%EF%BC%9A%E4%BD%BF%E7%94%A8%E6%96%B9%E6%B3%95%E3%80%81%E7%9B%8A%E8%99%95%E3%80%81%E5%89%AF%E4%BD%9C%E7%94%A8%E5%92%8C%E7%B5%90%E6%9E%9C/Wegovy 藥丸是每日口服的 semaglutide，用於成人體重管理。檢視標籤上的劑量步驟、服用方法、試驗結果和副作用。Mon, 02 Mar 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/mounjaro-%E8%88%87-ozempic%EF%BC%9A%E6%B8%9B%E9%87%8D%E6%97%85%E7%A8%8B%E4%B8%AD%E7%9A%84%E9%97%9C%E9%8D%B5%E5%B7%AE%E7%95%B0/https://mingo.fit/zh-hant/blog/mounjaro-%E8%88%87-ozempic%EF%BC%9A%E6%B8%9B%E9%87%8D%E6%97%85%E7%A8%8B%E4%B8%AD%E7%9A%84%E9%97%9C%E9%8D%B5%E5%B7%AE%E7%95%B0/Mounjaro（tirzepatide）vs Ozempic（semaglutide）：核准用途、劑量、頭對頭試驗結果、副作用及如何追蹤。Sun, 01 Mar 2026 00:00:00 GMT減重https://mingo.fit/zh-hant/blog/ozempic-%E8%88%87-wegovy%EF%BC%9Aglp-1-%E7%94%A8%E6%88%B6%E7%9A%84%E4%B8%BB%E8%A6%81%E5%B7%AE%E7%95%B0/https://mingo.fit/zh-hant/blog/ozempic-%E8%88%87-wegovy%EF%BC%9Aglp-1-%E7%94%A8%E6%88%B6%E7%9A%84%E4%B8%BB%E8%A6%81%E5%B7%AE%E7%95%B0/Ozempic 和 Wegovy 都含有 semaglutide。比較 FDA 標籤上的核準用途、劑量、給藥時間表和副作用。Sat, 28 Feb 2026 00:00:00 GMT藥物https://mingo.fit/zh-hant/blog/mounjaro%EF%BC%9A%E5%85%B6%E7%9B%8A%E8%99%95%E5%92%8C%E6%BD%9B%E5%9C%A8%E5%89%AF%E4%BD%9C%E7%94%A8%E6%8C%87%E5%8D%97/https://mingo.fit/zh-hant/blog/mounjaro%EF%BC%9A%E5%85%B6%E7%9B%8A%E8%99%95%E5%92%8C%E6%BD%9B%E5%9C%A8%E5%89%AF%E4%BD%9C%E7%94%A8%E6%8C%87%E5%8D%97/Mounjaro（tirzepatide）的核準用途、其GIP和GLP-1作用機制、劑量安排及標籤上列出的副作用。Fri, 27 Feb 2026 00:00:00 GMT藥物